Artivion (AORT) Other Non-Current Assets (2010 - 2026)
Artivion's (AORT) quarterly Other Non-Current Assets came in at $15.7 million in Q1 2026, down 37.44% YoY from $25.0 million in Q1 2025, and up 2.74% on a QoQ basis from $15.2 million in Q4 2025.
Artivion (AORT) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Artivion (AORT) has 17 years of Other Non-Current Assets data on file, last reported at $15.7 million in Q1 2026.
- Quarterly Other Non-Current Assets fell 37.44% year-over-year to $15.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.7 million (down 37.44% YoY) and the FY2025 annual result came in at $15.2 million, down 37.76% from the prior year.
- Other Non-Current Assets grew to $15.7 million in Q1 2026, from $15.2 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $29.1 million in Q3 2025 to a low of $7.1 million in Q3 2022.
- A 5-year average of $14.5 million and a median of $13.3 million in 2024 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets plunged 50.09% — and 2024, when it soared 175.28%.
- Tracing AORT's Other Non-Current Assets over 5 years: stood at $7.3 million in 2022, then increased by 21.19% to $8.9 million in 2023, then jumped by 175.28% to $24.5 million in 2024, then sank by 37.76% to $15.2 million in 2025, then rose by 2.74% to $15.7 million in 2026.
- The last three Other Non-Current Assets figures came in at $15.7 million (Q1 2026), $15.2 million (Q4 2025), and $29.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 3.23 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 616.40 Mn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 273.70 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 148.78 Mn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 215.10 Mn |
| 10 | Artivion | 1.37 Bn | 1.29 Bn | 80.52 Mn | 15.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.23 Mn |
| Mar 31, 2026 | 15.66 Mn |
| Dec 31, 2025 | 15.24 Mn |
| Sep 30, 2025 | 29.13 Mn |
| Jun 30, 2025 | 26.86 Mn |
| Mar 31, 2025 | 25.03 Mn |
| Dec 31, 2024 | 24.48 Mn |
| Sep 30, 2024 | 20.94 Mn |
| Jun 30, 2024 | 13.75 Mn |
| Mar 31, 2024 | 13.26 Mn |
| Dec 31, 2023 | 8.89 Mn |
| Sep 30, 2023 | 8.19 Mn |
| Jun 30, 2023 | 8.24 Mn |
| Mar 31, 2023 | 7.54 Mn |
| Dec 31, 2022 | 7.34 Mn |
| Sep 30, 2022 | 7.09 Mn |
| Jun 30, 2022 | 7.32 Mn |
| Mar 31, 2022 | 8.03 Mn |
| Dec 31, 2021 | 8.27 Mn |
| Sep 30, 2021 | 13.22 Mn |